Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
1400W dihydrochloride has been used:as a strong inhibitor of inducible nitric oxide to analyse its effect on intestinal ischemia/reperfusion (I/R) injury model in ratas inducible nitric oxide synthase (iNOS)-selective inhibitor, to elucidate the mechanism of PM10-induced endothelial dysfunctionto study its efficacy on renal ischemia/ reperfusion injury in ratsas iNOS inhibitor to investigate its ability to counteract spatial memory deficits after hypobaric hypoxia reoxygenation
Biochem/physiol Actions
1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase (iNOS).
Features and Benefits
This compound is featured on the Nitric Oxide Synthases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
10 mg in glass bottle
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :